Transforming brain research with AI and machine learning

Using machine learning, researchers are able to use data from the brain to glean deeper insights and apply this new knowledge in clinical settings.

BridgeBio partners with biomanufacturer Resilience to produce early-stage AAV gene therapies

BridgeBio has tapped biomanufacturing company National Resilience to produce two of its early-phase adeno-associated virus (AAV) gene therapies in a partnership designed to run beyond

October 4, 2023

Many young adults who began vaping as teens can’t shake the habit

G Kumar’s vaping addiction peaked in college at the University of Colorado, when flavored, disposable vapes were taking off.

June 12, 2024

The little-known Chinese biotech whose cancer drug beat Keytruda has global ambitions

Recent headlines about a potent new immunotherapy have mostly focused on the U.S. company helping to develop it. Less attention has been paid to Akeso,

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.